Study | Patients analysed; N | FU | Subtypes | Age; median years (range) | Gender; % males | |||
---|---|---|---|---|---|---|---|---|
HSCT | SDCT | HSCT | SDCT | HSCT | SDCT | |||
Aggregate comparative data | ||||||||
Bui-Nguyen et al21 | 38 | 45 | 55 (NR) | Various | 46 (19 to 65) | 43 (18 to 65) | 58 | 50 |
Aggregate case series data | ||||||||
Bertuzzi et al22 | 10 | NA | 35 (14 to 60) | DSRCT | 29 (NR) | NA | 100 | NA |
Bisogno et al23 | 14 | NA | 27 (NR) | DSRCT | 10 (2 to 17) | NA | 93 | NA |
Blay et al24 | 24 | NA | NR | Various | NR | NA | NR | NA |
Bokemeyer et al25 | 16 | NA | NR | Various | 45 (25 to 57) | NA | NR | NA |
Cook et al26 | 36 | NA | 44 (4 to 89) | DSRCT | 19 (8 to 46) | NA | 80 | NA |
Philippe-Chomette et al27 | 14 | NA | 23 (9 to 51) | DSRCT | NR (4 to 29) | NA | 86 | NA |
Individual cases data | ||||||||
55 studies | 142 | NA | Various | Various | 25 (1 to 65) | NA | NR | NA |
DSRCT, desmoplastic small-round cell tumour; FU, follow-up of the analysed patients in median months (range); HSCT, autologous haematopoietic stem cell transplantation following high-dose chemotherapy; N, number; NA, not applicable; NR, information not reported in the article; SDCT, standard-dose chemotherapy.